Week 1 - URTI, Oral lesions, Influenza, Salivary glands Flashcards

1
Q

Outline upper respiratory tract infections (URTIs).

A
  • Rhinitis, Tonsilitis, Pharyngitis, Epiglottitis, Laryngitis, Sinusitis.
  • Strong primary pathogens (e.g. diphtheria) in normal/secondary pathogens (streptococcus) in weak.
  • Contact is the most important risk factor - crowding, school, kindergarten, travel, congregations (unhygienic situations, transmitted through aerosols).
  • Influenced by many factors - immunity, nutrition, age, smoking, carrier states e.g. GABHS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Identify common pathogens of URTIs.

A
  • Nasopharynx - Rhinovirus (30-50%), parainfluenza viruses, RSV, adenovirus, coronavirus and influenza viruses.
  • Oropharynx (usually bacteria) - Group A Strep, corynebacterium, EBV, adenoviruses.
  • Epiglottis - H. influenzae.
  • Larynx-trachea - Parainfluenza, S. aureus.
  • Bronchi - Influenza virus, Strep pneumoniae, H. influenzae.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Provide an overview of pathogen microbiology:
• Characteristics of microbe promoting infection.
• Host defences preventing infection.
• Pathogenesis.

A

Characteristics of microbe promoting infection:
• Selective survival (microbe has strong preference for certain sites).
• High virulence organisms (infect normal healthy respiratory tract/evade defences).
• Low virulence organisms (secondary infections occur when host defences are weak).
• Factors affecting virulence: adhesion, invasiveness, toxigenicity, plasmids, bacterial products, appendages, infecting dose, route of infection, communicability.

Host defences preventing infection:
• Physical barriers: nasal hairs, cilia, cough & sneeze reflexes, bronchial mucus.
• Immunological barriers: tonsils, lymph nodes, antibodies, alveolar macrophages.
• Normal flora of upper respiratory tract (prevent pathogens from binding).

Pathogenesis:
• Organism enters respiratory tract, evades host defences and causes irritation/inflammation to respiratory mucosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
Outline the common cold (rhinitis):
• Aetiology.
• Transmission.
• Incubation period.
• Clinical features.
• Complications.
A

• Most common, seasonal, self-limiting.

Aetiology:
• Rhinovirus most common cause (>100 serotypes).
• Others - influenza, parainfluenza, corona (SARS), adenovirus and RSV.

Transmission:
• Highly contagious, droplets spread by sneezing, coughing or hand contact with the nose, eyes or face (hygiene measures required for prevention).

Incubation period:
• Incubation 2-4 days followed by sneezing, coughing and malaise for 3-6 days.
• Usually resolves by day 7 (with or without treatment) - treatment does not make much difference - maintaining good health and nutrition is important rather then taking antibiotics. Antibiotics prevent secondary infection).

Clinical features:
• Headache, nasal congestion, scratchy throat, clear watery rhinorrhoea. After 2-3 days, nasal discharge is thicker, cloudy and yellowish.
• Acute serous inflammation, catarrhal - excess mucous (catarrhal inflammation).
• Secondary bacterial infection common - suppurative (pus).

Complications:
• Sinusitis.
• Pharyngitis.
• Tonsilitis.
• Otitis media.
• Septicaemia.
• Nasal polyps - inflammatory (allergy) - long term complication usually seen in hypersensitivity/allergic people (inflammatory tissue accumulates under the mucosa - polyps).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Outline pharyngitis:
• Aetiology.
• Clinical features.
• Centor criteria.

A

• Inflammation of the pharynx (sore throat).

Aetiology:
• GAS Strep. pyogenes.
• Virus - rhinovirus, adenovirus, EBV etc.

Clinical features:
• Pain, headache, fever, myalgia, arthralgia (no cough).
• Bacteria - yellow white exudates on throat.

Centor criteria:
• 0 (unlikely) to 4 (likely).
• Fever, anterior lymphadenopathy, tonsilar exudate, no cough (each worth 1 point on the Centor criteria).

Sputum culture/microscopy:
• Gram positive streptococci in chains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outline epiglottitis:
• Aetiology.
• Clinical features.
• Complications.

A

• Inflammation of the epiglottis.

Aetiology:
• H. influenzae B.
• Can be due to strep.

Clinical features:
• Typically affects children, not common due to vaccine.
• Fever, dysphagia, drooling, hoarseness, stridor (severe distress in breathing).

Complications
• Inflammation can cause complete obstruction → urgent endotracheal intubation.

• Thumbprint sign on X-ray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline sinusitis.

A
  • Inflammation of sinuses, most commonly paranasal ducts (maxillary sinusitis). Can occur in frontal sinus. Inflammation, pus formation.
  • Chronic rhinosinusitis (CRS) - paranasal, >12 weeks. 3 types - associated with polyps, not associated with polyps and allergic (+/- polyps, allergic).
  • Characterised by fever, pain, nasal discharge, hyposmia/anosmia.
  • Requires long term antibiotic treatment and potential surgical treatment.
  • Usually mixed microbial flora, especially normal inhabitants of nasal cavity.
  • Often follows rhinitis - impairment of sinus drainage by inflammatory mucosal oedema
  • Build up of microbes within sinuses → damage and inflammation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
Outline diphtheria:
• Epidemiology.
• Aetiology.
• Transmission.
• Clinical features.
• Complications.
• Prevention.
A

Epidemiology:
• Rare in developed countries. Not common because of vaccination but there is lack of vaccination in developing countries because of different belief systems.

Aetiology:
• Corynebacterium diphtheria.
• Gram +ve, pleomorphic bacilli (each one looks different - Chinese letter pattern).
• Exotoxin AB (activity and binding).

Transmission:
• Contact, aerosol spread, primary pathogen.

Clinical features:
• High fever, SOB, sore throat, cough, hoarse voice, nausea and vomiting. Neck lymphadenopathy, bull neck.
• Mucosal necrosis with fibrinopurulent exudate (pseudomembrane) - formation of pseudomembrane (thick pus sticking on the surface of the ulcerated mucosa - over pharynx and tonsils).

Complications (due to systemic spread of exotoxin):
• Aspiration of pseudomembrane and airway obstruction, spread of exotoxin, myocarditis, heart failure, peripheral neuritis.
• Cutaneous diphtheria - non healing ulcer.

Prevention:
• Vaccination - DPT (diphtheria, pertussis, tetanus).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
Outline EBV - infectious mononucleosis (glandular fever):
• Aetiology.
• Transmission.
• Incubation period.
• Clinical features.
• Pathogenesis.
• Diagnosis.
• Prognosis.
• Complications.
A

Aetiology:
• Epstein- Barr virus (EBV).
• Herpes gp (10% by CMV - infectious mononucleosis occasionally caused by CMV - spread through saliva).

Transmission:
• Youth, close contact, saliva (kiss).

Incubation period:
• Incubation 1-2 months.

Clinical features:
• Adolescents and young adults.
• URTI (fever, sore throat, fatigue, malaise) + lymphadenopathy, splenomegaly, hepatitis.
• Enlarged spleen* - easy rupture - youth death* (may die with minor trauma).

Pathogenesis:
• EBV infect epithelium and B lymphocytes.
• EBV specific CD8+ T cells - defense (atypical lymphocytes) - protective mechanism - seen in peripheral blood smear - diagnosis is looking at atypical lymphocytes in peripheral blood.
• Viruses which enter upper respiratory tract → taken up by B lymphocytes → starts multiplying within B lymphocytes → infected B cells continue to divide and attack other organs.
• CD8 T lymphocytes - seen in peripheral blood - activated T lymphocytes (atypical, protective) kill infected B lymphocytes.

Diagnosis:
• Lymphocytosis with atypical lymphocytes (peripheral smear).
• Serology - heterophile antibody (monospot test).
• Monospot +ve (heterophile Ab) and rising titer of EBV antibody.
• Monospot - abnormal B lymphocytes produce many antibodies which are not normally seen e.g. heterophile Ab - specific to RBCs.
• Blood chemistry - altered liver enzymes.

Prognosis:
• Self limited (4-6 weeks then heals).

Complications:
• Hepatitis.
• Spleen rupture.
• Organ failure - fatal (e.g. meningitis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline coxsackie virus.

A
  • RNA virus. Enterovirus group. Faeco-oral, 2-6 day incubation.
  • Coxsackievirus A: herpangina, hand, foot and mouth disease.
  • Herpangina - fever, sore throat, oral, tiny papulovesicles → ulcers.
  • Hand, foot and mouth disease - fever, sore throat, dysphagia, oral, tiny papulovesicles, erythematous halo.

• Coxsackievirus B: myocarditis, pericarditis.

  • Myocarditis - fever, chest pain or asymptomatic → ventricular fibrillation (serious condition, can cause death due to VF).
  • Bornholm disorder: intercostal myositis. DDx - MI, pulm, embolism etc.
  • Coxsackie A - typically produce small blister-like lesions - hand, foot and mouth disease. Oral lesions also called herpangina.
  • Coxsackie B - myocarditis, pericarditis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe aphthous ulcers (canker sores).

A
  • Common, young age (<20yo), self-limited (few days/weeks).
  • Painful, superficial ulcers of unknown aetiology.
  • Covered by thin exudate, surrounded by hyperemia.
  • Associated with stress, autoimmune IBD and other disorders.
  • Sugar as a therapy - sugar on top and keep it there → causes hyperosmolar absorption of all the inflammatory fluid → healing/relief of ulcer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe pyogenic granuloma.

A
  • Inflammatory - granulation tissue.
  • Young age, pregnancy (AKA pregnancy tumour - very common).
  • May regress or heal as fibroma or osteoma (may regress if primary infection cleared or heal as a fibroma or bone formation within healed scar tissue - osteoma).
  • Looks like a tumour but it is excess granulation tissue due to chronic irritation, tooth caries, gingivitis → produces something similar to a tumour.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe fibroma.

A
  • Nodular swelling of fibrous tissue - scar tissue.
  • Chronic irritation - common on buccal mucosa, along bite lines (continuous damage by sharp teeth → produces swelling → fibrous scar tissue → healing scar). Reaction to chronic irritation - reactive connective tissue hyperplasia.
  • Firm nodule of scar tissue.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Outline oral cancers.

A
  • Head and neck 6th most common cancer in the world.
  • Male (4%), female (2%) of all cancers are oral.
  • Squamous cell carcinoma 95% of cases.
  • 95% occur after 40 years of age (~60y).
  • Location: Lips, tongue, floor of mouth, oropharynx (HPV).
  • Aetiology: Tobacco (commonest - usually secondary to smoking), alcohol, HPV, sunlight (UV radiation - lips). Sunlight etiology in lip cancers, HPV becoming more common - also involved in cervical cancer.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the pathogenesis of oral cancers.

A
  • From precursor lesions (leuko/erythroplakia).
  • Injury → hyperplasia → metaplasia → dysplasia (erythro/leuko) → carcinoma in situ (CIS) → carcinoma.
  • HPV-16 → loss of E1, E2 tumor suppressor genes (commonest strain of HPV - loss of E1 and E2 tumor suppressor genes leading to cancer).
  • Spread: cervical lymph nodes (stages) - spreads to cervical lymph nodes and then to distant organs.
  • Cancer starts from precursor lesion - injury due to any aetiology (e.g. smoking, HPV etc.) → initial damage causes hyperplasia → metaplasia (change to thick keratinized epithelium) → dysplasia (irregularity of cell division) → CIS → carcinoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Differentiate between leukoplakia and erythroplakia.

A

Leukoplakia:
• Asymptomatic, chronic, painless, white (excess keratin forms white plaque).
• Tobacco, irritation, infection, EBV, HIV.
• Thick keratinised epidermis, less vascular submucosa.
• Microscopy - 10% dysplasia/cancer (plenty of inflammatory cells within).
• Cannot be scraped off.

Erythroplakia:
• Asymptomatic, chronic, red (loss of keratin).
• Tobacco, alcohol.
• Thin dysplastic epidermis with vascular submucosa.
• Microscopy - 90% dysplasia/cancer (chances of cancer greater).

  • Important in oral lesions because represent early stage of malignancy (precursor to cancer caused by aetiology factors). But not all white/red patches are pre-malignant (any inflammation can also produce red patch. Chronic irritation can cause white patch).
  • Usually leukoplakia → erythroplakia → cancer (SCC). Sometimes straight to cancer (neither plakia) or erythroplakia → cancer. (Not every patch goes through leukoplakia/erythroplakia. Some cancers can start without either plakia).
  • White patch = more keratin.
  • Red patch = more inflammation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the pathogenesis of oral dysplasia and cancer.

A
  1. Normal mucosa exposed to irritation/injury e.g. tobacco, HPV.
  2. Hyperplasia (thickening).
  3. Excess keratin cells start becoming irregular because of mutation.
  4. Leukoplakia with irregularities.
  5. Starts producing erythroplakia (initially it is mixed leuko and erythroplakia (speckled) but then it becomes malignant erythroplakia).
  6. Malignant.

Metaplasia - normal epithelium becomes keratinised.
Dysplasia - irregularity of cell division (basement membrane intact, stage 0 cancer or CIS). When it starts spreading → cancer.

18
Q

Describe the morphology of oral squamous cell carcinoma.

A

Gross:
• May arise anywhere in oral cavity but the most common locations are the ventral surface of the tongue, floor of the mouth, lower lip, soft palate and gingiva.
• In early stages, these cancers appear as raised, firm, pearly plaques or as irregular, roughened or verrucous mucosal thickenings. Either pattern may be superimposed on a background of leukoplakia or erythroplakia.
• As these lesions enlarge they typically form ulcerated and protruding masses that have irregular and indurated or rolled borders.

Microscopy:
• Pleomorphic cells in clusters (no uniformity, very irregular, infiltrate, cause damage to own blood vessels (haemorrhage), inflammatory cells).
• Keratin pearls (keratin formation within nodules of cancer cells).
• Areas of inflammation, some necrosis and haemorrhage.

• Malignant cells form large nodules, inflammatory cells inbetween.

Clinical features:
• Patches inside mouth (leukoplakia, erythroplakia may become malignant).
• Bleeding in mouth.
• Difficulty or pain when swallowing.
• Lymph node involvement in 50% of tongue and 60% floor of mouth SCC at diagnosis.

19
Q

Describe verrucous carcinoma.

A
  • Warty, exophytic, white → ‘cauliflower’ like cancer.
  • Buccal mucosa, vestibule, gingiva.
  • Males > females; >60 years, tobacco and HPV infection (same aetiology).
  • Papillary hyperkeratosis over dysplastic epithelial overgrowth.
  • Low grade/well differentiated.
  • No/rare metastasis.
  • Wide excision is adequate (curative, good prognosis).
  • Hard keratin producing tumor. Type of carcinoma - becomes more whitish instead of becoming red. Normal keratin production although it is an infiltrating cancer.
  • Low grade cancer, well differentiated. Marked hyperkeratosis continuing without much infiltration.
20
Q

Describe hairy leukoplakia.

A
  • EBV virus - immunocompromised - AIDS.
  • White patches of fluffy hairy hyperkeratotic thickenings.
  • Lateral side of tongue more common (uni or bilateral),
  • Some times with candidiasis also.
  • Microscopy: acanthosis and balloon cells (loaded with EBV virus).
  • Leukoplakia like patch. Hairy because appears irregular rough surface - usually due to EBV virus infection in an immunocompromised host e.g. AIDS patient. White patch can be due to inflammation, chronic infection, candida infection.
  • Whenever you see white plaque → must take biopsy. Could be simple inflammation/infection or malignancy. Clinically you cannot tell the difference - red or white patch with/without symptoms → better to take biopsy
21
Q

Summary of oral cancers.

A

• Normal → hyperplasia/hyperkeratosis → mild/moderate dysplasia (leukoplakia) → severe dysplasia/CIS (erythroplakia) → SCC.

  • White lesion, symptomatic = hyperkeratosis.
  • White lesion, asymptomatic = dysplasia.
  • Gradual irregularity of cells (dysplasia).
  • Leukoplakia → erythroplakia → cancer.
  • Important to take biopsy.
22
Q

Describe the differences in the oral epithelium.

A
Parakeratinised:
• Less keratin with nuclei.
• Long dermal papilla.
• Buccal, lips, soft palate.
• Mobile area, less trauma.

Absorptive:
• Flexible, more mucous.
• Under surface tongue, floor of mouth.
• Mobile, more blood vessels, minor salivary glands.

Keratinised:
• Flat, thick keratin, no nuclei.
• Short dermal papilla.
• Gingiva and hard palate.
• Fixed area, exposed to trauma.
23
Q

Outline influenza.

A
  • Globally, over 4 million cases, 200,000 hospitalisations and 40,000 deaths per year (commonest acute respiratory infection, presents like an URTI).
  • Several types (influenza A, B & C) with each having a variety of strains; new strains each year (new vaccine each year). Type A and B most common.
  • Only infection where a new vaccine has to be created every year. Beginning of cycle involves identification of strains and development of vaccine. Not 100% effective because there are so many strains and many new strains appearing - prevents from 40-80% of influenza attacks.
  • More severe in susceptible population e.g. aged, young, pregnant, immunosuppressed, diabetes, chronic disease etc.
  • Incubation 1-5 days; contagious 24 hours before to 7 days after symptoms. Person to person spread - crowd, school, aged care etc.
  • Clinical: Mild URTI to high fever, exhaustion, malaise, sore throat, chills, headache, muscle aches and dry cough. Abdominal pain and diarrhoea especially in children.
  • Diagnosis: Nasopharyngeal swab for a rapid antigen test or PCR serum antibodies later (usually develop later).
  • Evolution - pandemics. Due to antigen variation → influenza spreads → spreads beyond borders with travel of people → pandemics (global attacks).
24
Q

Identify the different types of influenza and describe its pathogenesis.

A
  • Orthomyxovirus, single-stranded RNA virus.
  • Bound by a nucleoprotein that determines the virus type.
  • Type A, B and C (many strains, also many substrains).
  • ~500 surface molecules of haemagglutinin (“H”).
  • ~100 surface molecules of neuraminidase (“N”).
  • A (H1N1) and A (H3N2).
  • B Yamagatta, B Victoria etc. (named according to the place they were identified e.g. Brisbane).
  • C rare - vaccine A and B only (vaccines developed based on the most common strains in a given population).
  • Trivalent (2A and 1B).
  • Quadrivalent (2A and 2B).
  • Type A has many surface antigens - need to remember H and N antigen e.g. H1N1 - type of haemagglutinin and type of neuraminidase.
  • Haemagglutinin (H) attaches virus to cell surface - virus enters cell.
  • Neuraminidase (N) acts to release virus from cell surface - virus leaves cell.

Pathogenesis:

  1. Virus is transmitted via respiratory droplets (has incubation period of 1-5 days, is contagious 24 hours before and up to 4 days after the start of symptoms).
  2. Virus invades respiratory epithelial cells via the haemagglutinin (H) glycoprotein.
  3. Virus replicates in cells, triggers inflammation & causes damage to cells.
  4. Virus leaves cells via neuraminidase (N) glycoprotein.
25
Q

Outline influenza in Australia.

A

• Nationally, influenza at low levels than previous years.
• Nationally, influenza A (H3N2) is the most common.
• Vulnerable population, extremes of age - influenza very common in early age and later age but can occur at all ages.
• Vaccine - purified, inactivated vaccine - Fluvac (every year, new strain target).
- Trivalent (TIA): 2A (H3N2, H1N1) and 1B (Phuket).
- Quadrivalent (QIA): 2A & 2B (Phuket and Brisbane).

  • Vaccine produced every year: identify common strains → harvesting → purification → production of vaccine → testing → release to public.
  • Not 100% effective because new strains are consistently changing and coming up. Known as ‘influenza vaccine effectiveness’ → varies from 20-85% in a given population based on new vaccine strains. E.g. 24% vaccine effectiveness = 24% less chance of getting influenza in vaccinated people.
26
Q

What is antigenic drift and shift?

A

Antigenic drift:
• A mechanism for variation in viruses that involves the accumulation of mutations within the genes that code for antibody-binding sites. This results in a new strain of virus particles which cannot be inhibited as effectively by the antibodies that were originally targeted against previous strains, making it easier for the virus to spread throughout a partially immune population.
• The natural mutation over time of known strains of influenza which may lead to a loss of immunity, or in vaccine mismatch. Antigenic drift occurs in all types of influenza including influenza virus A, influenza B and influenza C.
• Epidemics of influenza occur through mutations of the haemagglutin and neuraminiase antigens that allow the virus to escape most host antibodies.

Antigenic shift:
• The process by which two or more different strains of a virus, or strains of two or more different viruses, combine to form a new subtype having a mixture of the surface antigens of the two or more original strains.
• Occurs only in influenza virus A because it infects more than just humans.
• Pandemics which last longer and are more widespread than epidemics may occur when both the haemagglutinin and neuraminidase are replaced through recombination of RNA segments with those of animal viruses, making all animals susceptible to the new influenza virus.

  • Bird flu - influenza A virus with H5N1 strain.
  • Swine flu - influenza A virus with H1N1 strain.
27
Q
Outline severe acute respiratory syndrome (SARS):
• Aetiology.
• Transmission.
• Incubation period.
• Clinical features.
• Diagnosis.
A

Aetiology:
• New Corona virus - quick entry/quick exit (example of a quick entry and quick exit of a new virus. New virus but successfully controlled).
• 10/3/2003 first case, virus identified 27/3/2003 (atypical pneumonia, identified for the first time in 2003).

Transmission:
• Close contact, respiratory droplets or fomite (person to person).

Incubation period:
• Incubation typically 2 to 7 days.

Clinical features:
• Fever, chills, malaise and headache. High morbidity and mortality, pneumonia.
• Other - myalgia, cough, dizziness, rigors, sore throat, runny nose, productive cough.
• 12% ICU care, 3% deaths → SARS.

Diagnosis:
• Clinical - symptoms, history of travel, contact.
• CXR - acute, features of atypical pneumonia/ARDS (decreased lymphocytes).
• Lab - neutrophilia, lymphopenia, increased CRP and LDH (inflammatory markers).
• Serology - ELISA, Ab after 10 days (develop late).
• PCR - blood, serum, sputum.

28
Q

Outline atrophic rhinitis.

A

• AKA Rhinitis sicca/dry nose. Rare condition.
• Chronic atrophy of nasal mucosa and turbinates - resulting in thick greenish foul smelling pus and dilation of the nasal space because of total atrophy of bone and mucosa.
• Characterised by nasal crusting (greenish pus that dries up), fetor (bad smell from patient but the patient themselves will not smell anything due to anosmia - because total atrophy) and widening of the space (anosmia).
• 2 types:
- Primary - unknown etiology (maybe immune or heredity).
- Secondary - chronic sinusitis (secondary infection), trauma, surgery, granulomatous disease.
• Coccobacillus (common bacteria isolated from greenish pus).
• Antibiotics to prevent secondary infection.

29
Q

Outline the salivary glands.

A

• Major - parotid, submandibular, sublingual.
- Parotid gland opens through one single duct and maxillary molar. Rich in enzymes for digestion.
- Submandibular gland open in front through single duct, both sides. Mixed enzymes and mucus.
- Sublingual gland opens up with multiple ducts linearly on either side of the frenulum. Mostly mucus, only for lubrication.
• Minor - many hundreds, small, widespread all over the oral cavity.
• Serous, mucinous and mixed types.
• Acini and ducts (pancreas) - salivary glands just like pancreas - have acini plus ducts. Ducts join to form major ducts.

30
Q

What are the constituents and functions of saliva?

A
Constituents:
• Amylases.
• Cystatins.
• Histatins.
• Mucins.
• Perioxidases.
• Carbonic anhydrases.
• Lipase.
• Proline-rich proteins.
• Statherins.
Functions:
• Lubrication.
• Digestion.
• Mineralisation of teeth.
• Speech - complex.
• Buffering - maintain pH.
• Tissue coating.
• Anti bacterial, viral and fungal.
31
Q

Outline salivary gland disorders.

A

Inflammations:
• Xerostomia - secondary condition where there is dryness in the mouth due to damage to the salivary gland.
• Siladenitis - salivary gland inflammation.
• Sialolithiasis - stone formation - usually chronic inflammation.
• Mumps, Sjorgen and Sicca syndrome - autoimmune disorders.

Neoplasms/tumours:
• Pleomorphic adenoma - benign - most common.
• Warthins tumour - second common.
• Mucoepidermoid carcinoma - rare.
• Carcinoma ex Pleomorphic adenoma - previous pleomorphic adenoma.

32
Q

Outline siladenitis.

A
  • Inflammation of salivary glands.
  • Parotid and submandibular most common. Inflammation of parotid raises ear.
  • Caused by dehydration, xerostomia, trauma, infection.
  • Most common in post operative and ICU patients (due to dehydration).

Pathogenesis:
• Dry mouth (xerostomia), drying of secretions which causes block → secondary inflammation and infection. Dehydration → dryness of mouth and block of salivary gland secretions. Ductal block common cause.
• Mumps - bacterial infection.
• Sjogren’s - autoimmune sialdenitis (parotitis) - common in parotid gland.

• Chronic sialadenitis - chronic, stone in duct. Sialolithiasis and fibrosis. Common in submandibular. (When cause is chronic → causes total atrophy, fibrosis of gland and drying up of the secretions → leads to formation of stone in the ducts).

Clinical features:
• Abnormal tastes, foul tastes, dry mouth, fever, pain (especially when eating).
• Swelling of the face, redness over the side of the face or upper neck.

33
Q

Outline xerostomia.

A
  • Dry mouth ‘decreased saliva’.
  • Common clinically, 1/3 of population, age (usually associated with ageing).
  • Causes - drugs, stress, fever, anticholinergics, antipsychotic, sedatives, antihistaminics, vitamin C etc.
  • Autoimmune - Sjogren and SICCA syndrome.
  • Clinical features - dry mouth, atrophy of papillae of tongue with fissuring (leads to fissuring of tongue), ulcerations.
  • Complications - caries (dryness effects health of other structures in the mouth e.g. teeth), candidiasis (secondary infection - common in chronic xerostomia), dysphagia, speaking difficulty.
34
Q

Outline Sjogren syndrome.

A

• Autoimmune Sialadenitis.

2 types:
• Primary (SICCA syndrome - Sjogren International Consortium) - 50% - systemic, T cell mediated → ducts. Dryness of mouth/eyes, inflammation of salivary glands alone.
• Secondary (with other autoimmune disorders) - 50% - with RA, SLE, SS (systemic sclerosis) etc.

Clinical:
• 90% females (very common in females - autoimmune disorders common in females → very sensitive).
• Dry eyes (with conjunctivitis), mouth, caries, speech and taste abnormalities, dysphagia (difficulty swallowing because of dry mouth).

Diagnosis:
• Anti-SS-A/SS-B (AKA Anti RO and La). Specific - many autoantibodies - anti-SS-A/SS-B common (single stranded).
• Labial biopsy - atrophy, chronic inflammation. Associated with other autoimmune disorders. Microscopically, just chronic inflammation (lymphocytes) and atrophy.

Complications:
• Lymphoma and cancer (most autoimmune diseases can result in lymphoma or other cancers of the salivary gland. Rare).

35
Q

Outline mumps.

A

• Paramyxovirus, single serotype. Infects only once in lifetime. (Reasonably common but has decreased due to vaccination. Single serotype therefore, once you have the antibodies - usually don’t get attack again. If no mumps as a child/no vaccination → may get it as an adult).
• Droplet inhalation, enlarged lymph nodes, gland ductal.
• Epithelial cells (secondary damage), inflammation, activation of T lymphocytes (T cell mediated immunity).
• Aseptic meningitis, orchitis (inflammation of testes) and pancreas (acute pancreatitis) - mumps can cause infections of other organs. *EXAM HINT.
• Clinical: fever, swollen painful parotid glands, orchitis.
• Morphology:
- Bilateral in 70%, enlarged, reddish brown. Parotid glands common.
- Microscopy - ductal chronic inflammation.
- Orchitis - inflammation with focal infarction.
- CNS - patchy demyelination and lymphocytes.
• Vaccine has reduced incidence 99%.

36
Q

Outline pleomorphic adenoma.

A
  • Pleo: multiple tissues - epithelial and connective tissue.
  • Benign mixed tumor (epithelial and CT).
  • Commonest neoplasm of salivary glands - 80% (especially in parotid gland).
  • Adults, slow growth, asymptomatic.
  • Single, irregular, nodular, mobile, firm, capsule not well developed, often produce extensions into surrounding tissue - making surgical excision difficult (recurrent).
  • Gross specimen - solid, grey-white, translucent blue areas of cartilage and myxoid tissue.
  • Microscopy - epithelial and connective tissues.
  • Pathogenesis - arise from myoepithelial cells.
  • Benign tumor of myoepithelial cells inside the salivary glands - specialised cells which produce both CT and glandular tissue. (Unlike other tumours - not a single type - both epithelial and CT elements in tumour). Can grow large or small, asymptomatic except for its size. Although benign, often multiple. If not complete excision → will recur.
  • Gross - grey-white.
  • Microscopy - epithelial and CT. Whole tumor is well encapsulated. Normal tissue outside tumor.
37
Q

Outline carcinoma ex pleomorphic adenoma.

A
  • Carcinoma arises after many years in a pleomorphic adenoma*
  • 10% at 10 years, highly aggressive, mortality 50% at 5 years.
  • Within tumor, see epithelial and CT elements. When pleomorphic adenoma remains for many years → carcinoma arises within these tumors - carcinoma ex pleomorphic adenoma. Rare, not very common. Aggressive cancer → can kill within 5 years.
38
Q

Outline warthins tumour.

A

• 7-8% of salivary tumours (second most common salivary gland benign neoplasm).
• Papillary Cystadenoma Lymphomatosum (tumour due to inclusion of lymphoid tissue into gland).
• Males, smokers common, late age.
• Benign, painless, 85% unilateral.
• Found only in parotid*
• Recurrence in 2% cases only (reasonably benign - like a foreign body in salivary gland e.g. tonsils, tissue).
• Morphology:
- 1-5cm, round to oval, capsulated.
- Double layer of neoplastic epithelium folded around dense lymphoid tissue with cystic spaces.
• Not common. Benign tumor with lymphoid tissue. No inflammation, like normal tonsils.

39
Q

Outline mucoepidermoid carcinoma.

A
  • 8% of salivary gland tumors but commonest carcinoma, common in parotids 70%.
  • Low to high grade, large.
  • Both squamous, mucous and intermediate cells.
  • Just like a mixed benign tumor, there is also a mixed carcinoma in salivary glands. Like pleomorphic adenoma but cancerous. This and pleomorphic adenoma most common.
40
Q

Outline adenoid cystic carcinoma.

A
  • Minor salivary glands, cheek, palate.
  • Slow growing, painful, ulcerated.
  • Multiple cystic spaces lined by cancer cells. Occurs in minor salivary glands (anywhere e.g. palate, cheek, lips etc.). Carcinoma producing multiple cystic spaces.
41
Q

Outline nasopharyngeal carcinoma.

A
  • A 36-year-old Chinese woman presents with persistent sinus pain and bloody nasal discharge. Examination: large irregular, haemorrhagic, nasopharyngeal mass.
  • Important points - middle aged woman, Chinese.
  • High incidence in Asian people and strong epidemiological link to Epstein-Barr Virus infection.
  • Extremely radiosensitive; 50% 5yr survival even for advanced stage.
  • Microscopy: very pleomorphic epithelial cells (high grade), plenty of lymphocytes.
  • Immunostains +ve for EBV.

• Very high-grade epithelial cancer with plenty of lymphocytes. Immunostains positive for EBV. Virus related cancer → nasopharyngeal carcinoma - common in Asian people.

42
Q

Outline Wegener’s granulomatosis.

A

• 35 year old man presents with runny nose, pus discharge, persistent sinusitis for 6 months. (Cold, discharge, sinusitis - chronic infection). Examination: Saddle nose and multiple ulcers.
• Investigations show classic features of:
1. Necrotising granulomas of upper respiratory tract.
2. Necrotising vasculitis of small vessels in lungs.
3. C-ANCA positivity in the serum (>95% of patients).
• Crescentic glomerulonephritis.
• Males > females, age ~40 years (middle age).
• Ulcers, granulomas and sinusitis of upper respiratory tract.
• Treat - immunosuppression.

  • One of the autoimmune vasculitis disorders. When it affects the kidney → rapidly progressive glomerulonephritis.
  • Saddle nose - depression of the nasal bridge.
  • Ulcers everywhere - oral cavity, palate. Sometimes ulcers can be so deep that they can cause perforation.